Molmart Limited

Intends to use the very latest DNA technology and combine it with their own in-house informatics platform.

Summary

Molmart Limited is a genomics company developing a potentially life-changing diagnostic technology for sufferers of an undiagnosed genetic disorder. Rare diseases currently affect an estimated 350 million people worldwide, some of which have the potential to be severely life threatening or life-compromising.
https://globalgenes.org/rare-diseases-facts-statistics/[LP1] [LT2]

The Company is focused on furthering the capabilities of Whole Genome Sequencing (‘WGS’), the process of determining the complete DNA sequence of an organism's genome at a single time (Genoma, “What is Whole Genome Sequencing?”, 2018).